Duality Advisers, LP Danaher Corp Transaction History

Duality Advisers, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$224.58 - $256.19 $5.01 Million - $5.72 Million	22,318 New	22,318 $5.57 Million
Q1 2023 Jun 27, 2023	SELL	$239.75 - $277.0 $1.35 Million - $1.56 Million	-5,626 Reduced 69.99%	2,412 $607,000
Q4 2022 Feb 07, 2023	BUY	$241.42 - $282.29 $1.94 Million - $2.27 Million	8,038 New	8,038 $2.13 Million
Q4 2021 Feb 02, 2022	SELL	$292.08 - $329.01 $361,887 - $407,643	-1,239 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$272.21 - $332.43 $337,268 - $411,880	1,239 New	1,239 $377,000
Q2 2021 Aug 09, 2021	SELL	$225.08 - $271.69 $3.12 Million - $3.77 Million	-13,875 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$212.38 - $245.9 $5.3 Million - $6.14 Million	-24,952 Reduced 64.26%	13,875 $3.12 Million
Q4 2020 Feb 09, 2021	BUY	$212.5 - $245.46 $8.25 Million - $9.53 Million	38,827 New	38,827 $8.63 Million
Q3 2020 Nov 12, 2020	SELL	$177.16 - $215.33 $2.46 Million - $2.99 Million	-13,886 Closed	0 $0
Q2 2020 Jul 29, 2020	BUY	$128.7 - $176.83 $1.79 Million - $2.46 Million	13,886 New	13,886 $2.46 Million

2,525

550M

7.1M

5.14M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $150B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.